Neurogene Inc (NGNE) short interest & short volume · 5.1M shares short
Neurogene Inc official short interest (FINRA, twice monthly) and daily short volume (FINRA Reg SHO), with history, % of float and days to cover.
What changed
NGNE short interest rose 2.4% to 5.1M shares in the Oct 15, 2026 report (14.4 days to cover). Daily short volume averaged 62.8% of volume over the last 20 sessions, down from 71.9% the 20 sessions before, the 74th percentile of its own 20-day averages since Sep 23, 2025.
Short interest
Official, twice monthly · settled Oct 15, 2026
- Shares short
- 5.1M
- prior 5.0M
- % of float
- 157.6%
- float 3.2M
- Days to cover
- 14.4
- avg vol 355K
- Change vs prior report
- +2.4%
Days to cover is short interest divided by FINRA's average daily volume for the period: how many average days of trading it would take shorts to buy back.
% of float uses the current float for every report (no float was stored with older reports).
Source: FINRA equity short interest (twice monthly) · Settlement Oct 15, 2026
Daily short volume
Share of each day's volume sold short · FINRA Reg SHO
- Latest (Nov 2)
- 64.4%
- 46K of 71K
- 20-day average
- 62.8%
- prior 71.9%
- Percentile vs own history
- 74th
- 233 periods since 2025
Loading prices…
Source: FINRA Reg SHO daily short sale volume · Latest Nov 2, 2026
Short squeeze score (model)
Price since settlement: +11.4%
Model, not a forecast: 40 pts short interest % of float (full at 30%), 25 pts days to cover (full at 10), 15 pts rise in short interest since the prior report (full at +50%), 20 pts price gain since the settlement date (full at +25%). Missing inputs score 0.
NGNE's squeeze score and its inputs with Lician Pro.Start 3-day trial — $149/yr
Market-wide: most shorted stocks, biggest changes and unusual short volume · NGNE overview
| Date | Short | Total | Short % of volume |
|---|---|---|---|
| 2026-11-02 | 45,753 | 71,052 | 64.4% |
| 2026-10-30 | 59,372 | 81,547 | 72.8% |
| 2026-10-29 | 53,662 | 103,141 | 52.0% |
| 2026-10-28 | 155,305 | 252,783 | 61.4% |
| 2026-10-27 | 169,944 | 210,355 | 80.8% |
| 2026-10-26 | 24,202 | 46,815 | 51.7% |
| 2026-10-23 | 27,141 | 48,348 | 56.1% |
| 2026-10-22 | 40,034 | 85,358 | 46.9% |
| 2026-10-21 | 268,351 | 304,036 | 88.3% |
| 2026-10-20 | 54,952 | 75,615 | 72.7% |
Healthcare peers with similar quant ratings
NGNE is rated 1.66 of 5 among 532 rated Healthcare stocks (Lician quant rating, Nov 4, 2026). How the rating works
- RGNX short interest1.69 · Sell · stock
- MDGL short interest1.68 · Sell · stock
- MNPR short interest1.67 · Sell · stock
- WVE short interest1.67 · Sell · stock
- CABA short interest1.65 · Sell · stock
- GLSI short interest1.64 · Sell · stock
- KRRO short interest1.64 · Sell · stock
- OCUL short interest1.63 · Sell · stock
NGNE short interest FAQ
What is NGNE's short interest?
Neurogene Inc (NGNE) had 5.1M shares sold short and not yet covered in FINRA's Oct 15, 2026 settlement report.
How many days to cover does NGNE have?
14.4 days: 5.1M shares short divided by an average daily volume of 355K for the Oct 15, 2026 period.
Is NGNE short interest rising or falling?
NGNE short interest rose (+2.4%) from 5.0M to 5.1M shares in the Oct 15, 2026 report.
Is NGNE a short squeeze candidate?
Lician's squeeze watch scores NGNE 75 out of 100 (high) from the Oct 15, 2026 report: short interest % of float 40/40, days to cover 25/25, change in short interest vs prior report 0.7/15, price change since settlement date 9.1/20. It is a transparent model of how crowded the short side is, not a forecast that a squeeze will happen.
What share of NGNE daily volume is sold short?
62.8% on average over the last 20 sessions to Nov 2, 2026 (FINRA Reg SHO daily short volume; the 74th percentile of its own 20-day averages). Short volume counts market makers' same-day short sales, so it is not short interest.
What was NGNE's latest FINRA short volume?
On Nov 2, 2026, cached FINRA short volume for Neurogene Inc (NGNE) was 45,753 shares, 64.4% of 71,052 total volume.
How many NGNE short-volume sessions are listed on this page?
This page lists 10 cached FINRA short-volume sessions for Neurogene Inc (NGNE), from Oct 20, 2026 through Nov 2, 2026.
How did NGNE short volume percent change from the prior cached session?
Cached FINRA short volume for Neurogene Inc (NGNE) moved from 72.8% on Oct 30, 2026 to 64.4% on Nov 2, 2026, down 8.4 percentage points.
Not investment advice. Figures as filed or reported, not a live feed.